Lamina-specific abnormalities of NMDA receptor-associated postsynaptic protein transcripts in the prefrontal cortex in schizophrenia and bipolar disorder

Neuropsychopharmacology

Volumn 33, Issue 9, 2008, Pages 2175-2186

  Beneyto, Monica ^a,b   Meador Woodruff, James H ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

Depression; Glutamate; In situ hybridization; Ionotropic receptors; Postmortem; Receptor autoradiography

Indexed keywords

2 AMINO 4 PHOSPHONOMETHYL 3 HEPTENOIC ACID; 3 (2 CARBOXY 2 PHENYLETHENYL) 4,6 DICHLORO 1H INDOLE 2 CARBOXYLIC ACID; DIZOCILPINE; GLUTAMIC ACID; IFENPRODIL; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; POSTSYNAPTIC DENSITY PROTEIN 95;

ADULT; ARTICLE; BIPOLAR DISORDER; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG RECEPTOR BINDING; FEMALE; HUMAN; HUMAN TISSUE; MAJOR DEPRESSION; MALE; NEUROTRANSMISSION; NUCLEOTIDE SEQUENCE; PATHOPHYSIOLOGY; PREFRONTAL CORTEX; PRIORITY JOURNAL; RECEPTOR INTRINSIC ACTIVITY; SCHIZOPHRENIA;

ADULT; ANALYSIS OF VARIANCE; AUTORADIOGRAPHY; BIPOLAR DISORDER; FEMALE; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MEMBRANE PROTEINS; MIDDLE AGED; NERVE TISSUE PROTEINS; NEUROFILAMENT PROTEINS; NUCLEAR PROTEINS; POSTMORTEM CHANGES; PREFRONTAL CORTEX; PROTEIN BINDING; RECEPTORS, N-METHYL-D-ASPARTATE; REGRESSION ANALYSIS; RNA, MESSENGER; SCHIZOPHRENIA; TRANSCRIPTION FACTORS;

EID: 47249164327     PISSN: 0893133X     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.npp.1301604     Document Type: Article

References (95)

1. Akbarian S, Sucher NJ, Bradley D, Tafazzoli A, Trinh D, Hetrick WP et al (1996a). Selective alterations in gene expression for NMDA receptor subunits in prefrontal cortex of schizophrenics. J Neurosci 16: 19-30.
2. Akbarian S, Sucher NJ, Bradley D, Tafazzoli A, Trinh D, Hetrick WP et al (1996b). Selective alterations in gene expression for NMDA receptor subunits in prefrontal cortex of schizophrenics. J Neurosci 16: 19-30.
3. Baron BM, Siegel BW, Harrison BL, Gross RS, Hawes C, Towers P (1996). [3H]MDL 105,519, a high-affinity radioligand for the N-methyl-D- aspartate receptor-associated glycine recognition site. J Pharmacol Exp Ther 279: 62-68.
4. Barria A, Malinow R (2002). Subunit-specific NMDA receptor trafficking to synapses. Neuron 35: 345-353.
5. Barria A, Malinow R (2005). NMDA receptor subunit composition controls synaptic plasticity by regulating binding to CaMKII. Neuron 48: 289-301.
6. Belsham B (2001a). Glutamate and its role in psychiatric illness. Hum Psychopharmacol 16: 139-146.
7. Belsham B (2001b). Glutamate and its role in psychiatric illness. Hum Psychopharmacol 16: 139-146.
8. Benes FM, Vincent SL, Marie A, Khan Y (1996). Up-regulation of GABAA receptor binding on neurons of the prefrontal cortex in schizophrenic subjects. Neuroscience 75: 1021-1031.
9. Braff DL, Swerdlow NR, Geyer MA (1999). Symptom correlates of prepulse inhibition deficits in male schizophrenic patients. Am J Psychiatry 156: 596-602.
10. Burnashev N (2005). Dynamic modulation of AMPA receptor-mediated synaptic transmission by polyamines in principal neurons. Focus on 'polyamines modulate AMPA receptor-dependent synaptic response in immature layer ν pyramidal neurons'. J Neurophysiol 93: 2371.
11. Burnashev N, Khodorova A, Jonas P, Helm PJ, Wisden W, Monyer H. et al (1992). Calcium-permeable AMPA-kainate receptors in fusiform cerebellar glial cells. Science 256: 1566-1570.
12. Clinton SM, Meador-Woodruff JH (2004). Abnormalities of the NMDA receptor and associated intracellular molecules in the thalamus in schizophrenia and bipolar disorder. Neuropsychopharmacology 29: 1353-1362.
13. Condorelli DF, Conti F, Gallo V, Kirchhoff F, Seifert G, Steinhauser C et al (1999). Expression and functional analysis of glutamate receptors in glial cells. Adv Exp Med Biol 468: 49-67.
14. Condorelli DF, Dell'Albani P, Corsaro M, Barresi V, Giuffrida Stella AM (1993). AMPA-selective glutamate receptor subunits in astroglial cultures. J Neurosci Res 36: 344-356.
15. Craven SE, Bredt DS (1998). PDZ proteins organize synaptic signaling pathways. Cell 93: 495-498.
16. Dracheva S, Marras SA, Elhakem SL, Kramer FR, Davis KL, Haroutunian V (2001). N-methyl-D-aspartic acid receptor expression in the dorsolateral prefrontal cortex of elderly patients with schizophrenia. Am J Psychiatry 158: 1400-1410.
17. Dracheva S, McGurk SR, Haroutunian V (2005). mRNA expression of AMPA receptors and AMPA receptor binding proteins in the cerebral cortex of elderly schizophrenics. J Neurosci Res 79: 868-878.
18. Du J, Gray NA, Falke CA, Chen W, Yuan P, Szabo ST et al (2004). Modulation of synaptic plasticity by antimanic agents: the role of AMPA glutamate receptor subunit 1 synaptic expression. J Neurosci 24: 6578-6589.
19. Duncan GE, Moy SS, Lieberman JA, Koller BH (2006). Effects of haloperidol, clozapine, and quetiapine on sensorimotor gating in a genetic model of reduced NMDA receptor function. Psychopharmacology (Berl) 184: 190-200.
20. Duncan GE, Moy SS, Perez A, Eddy DM, Zinzow WM, Lieberman JA et al (2004). Deficits in sensorimotor gating and tests of social behavior in a genetic model of reduced NMDA receptor function. Behav Brain Res 153: 507-519.
21. Ehlers M, Fung E, O'Brien R, Huganir R (1998). Splice variant-specific interaction of the NMDA receptor subunit NR1 with neuronal intermediate filaments. J Neurosci 18: 720-730.
22. Ehlers MD, Tingley WG, Huganir RL (1995). Regulated subcellular distribution of the NR1 subunit of the NMDA receptor. Science 269: 1734-1737.
23. Feldmeyer D, Egger V, Lubke J, Sakmann B (1999). Reliable synaptic connections between pairs of excitatory layer 4 neurones within a single 'barrel' of developing rat somatosensory cortex. J Physiol 521(Part 1): 169-190.
24. Feldmeyer D, Lubke J, Silver RA, Sakmann B (2002). Synaptic connections between layer 4 spiny neurone-layer 2/3 pyramidal cell pairs in juvenile rat barrel cortex: physiology and anatomy of interlaminar signalling within a cortical column. J Physiol 538: 803-822.
25. Fukaya M, Kato A, Lovett C, Tonegawa S, Watanabe M (2003). Retention of NMDA receptor NR2 subunits in the lumen of endoplasmic reticulum in targeted NR1 knockout mice. Proc Natl Acad Sci USA 100: 4855-4860.
26. Garner CC, Nash J, Huganir RL (2000). PDZ domains in synapse assembly and signalling. Trends Cell Biol 10: 274-280.
27. Gerfen CR, McGinty JF, Young III WS (1991). Dopamine differentially regulates dynorphin, substance P, and enkephalin expression in striatal neurons: in situ hybridization histochemical analysis. J Neurosci 11: 1016-1031.
28. Geyer MA, Braff DL (1987). Startle habituation and sensorimotor gating in schizophrenia and related animal models. Schizophr Bull 13: 643-668.
29. Grillon C, Ameli R, Charney DS, Krystal J, Braff D (1992). Startle gating deficits occur across prepulse intensities in schizophrenic patients. Biol Psychiatry 32: 939-943.
30. Harrison PJ, Heath PR, Eastwood SL, Burnet PW, McDonald B, Pearson RC (1995). The relative importance of premortem acidosis and postmortem interval for human brain gene expression studies: selective mRNA vulnerability and comparison with their encoded proteins. Neurosci Lett 200: 151-154.
31. Harrison PJ, Kleinman JE (2000). Methodological issues. In: Harrison PJ, Roberts GW (eds). The Neuropathology of Schizophrenia. Oxford University Press: New York, pp 339-350.
32. Harrison PJ, Procter AW, Barton AJ, Lowe SL, Najlerahim A, Bertolucci PH et al (1991). Terminal coma affects messenger RNA detection in post mortem human temporal cortex. Brain Res Mol Brain Res 9: 161-164.
33. Hashimoto K, Mantione CR, Spada MR, Neumeyer JL, London ED (1994). Further characterization of [3H]ifenprodil binding in rat brain. Eur J Pharmacol 266: 67-77.
34. Hashimoto T, Volk DW, Eggan SM, Mirnics K, Pierri JN, Sun Z et al (2003). Gene expression deficits in a subclass of GABA neurons in the prefrontal cortex of subjects with schizophrenia. J Neurosci 23: 6315-6326.
35. Hashimoto T, Arion G, Unger T, Volk DW, Mirnics K, Lewis DA (2005). Analysis of gaba-specific transcriptome in the prefrontal cortex of subjects with schizophrenia. Soc Neurosci Abstr 35, 675.4.
36. Healy DJ, Haroutunian V, Powchik P, Davidson M, Davis KL, Watson SJ et al (1998). AMPA receptor binding and subunit mRNA expression in prefrontal cortex and striatum of elderly schizophrenics. Neuropsychopharmacology 19: 278-286.
37. Healy DJ, Meador-Woodruff JH (1999). Ionotropic glutamate receptor modulation of 5-HT6 and 5-HT7 mRNA expression in rat brain. Neuropsychopharmacology 21: 341-351.
38. Hertzmann M, Reba RC, Kotlyarov EV (1990). Single photon emission computed tomography in phencyclidine and related drug abuse. Am J Psychiatry 147: 255-256.
39. Hsueh YP, Sheng M (1998). Anchoring of glutamate receptors at the synapse. Prog Brain Res 116: 123-131.
40. Huettner JE, Bean BP (1988). Block of N-methyl-D- aspartate-activated current by the anticonvulsant MK-801: selective binding to open channels. Proc Natl Acad Sci USA 85: 1307-1311.
41. Ibrahim H, Healy D, Hogg AJ, Meador-Woodruff J (2000a). Nucleus-specific expression of ionotropic glutamate receptor subunit mRNAs and binding sites in primate thalamus. Brain Res Mol Brain Res 79: 1-17.
42. Ibrahim HM, Hogg Jr AJ, Healy DJ, Haroutunian V, Davis KL, Meador-Woodruff JH (2000b). Ionotropic glutamate receptor binding and subunit mRNA expression in thalamic nuclei in schizophrenia. Am J Psychiatry 157: 1811-1823.
43. Jabs R, Kirchhoff F, Kettenmann H, Steinhauser C (1994). Kainate activates Ca(2+)-permeable glutamate receptors and blocks voltage-gated K+ currents in glial cells of mouse hippocampal slices. Pflugers Arch 426: 310-319.
44. Kennedy MB (1997). The postsynaptic density at glutamatergic synapses. Trends Neurosci 20: 264-268.
45. Kingsbury AE, Foster OJ, Nisbet AP, Cairns N, Bray L, Eve DJ et al (1995). Tissue pH as an indicator of mRNA preservation in human post-mortem brain. Brain Res Mol Brain Res 28: 311-318.
46. Kondoh T, Nishizaki T, Aihara H, Tamaki N (2001). NMDA-responsible, APV-insensitive receptor in cultured human astrocytes. Life Sci 68: 1761-1767.
47. Kornhuber J, Mack-Burkhardt F, Riederer P, Hebenstreit GF, Reynolds GP, Andrews HB et al (1989). [3H]MK-801 binding sites in postmortem brain regions of schizophrenic patients. J Neural Transm 77: 231-236.
48. Lalo U, Pankratov Y, Kirchhoff F, North RA, Verkhratsky A (2006). NMDA receptors mediate neuron-to-glia signaling in mouse cortical astrocytes. J Neurosci 26: 2673-2683.
49. Magnusson KR (1998). Aging of glutamate receptors: correlations between binding and spatial memory performance in mice. Mech Ageing Dev 104: 227-248.
50. Magnusson KR (2000). Declines in mRNA expression of different subunits may account for differential effects of aging on agonist and antagonist binding to the NMDA receptor. J Neurosci 20: 1666-1674.
51. McCullumsmith RE, Clinton SM, Meador-Woodruff JH (2004). Schizophrenia as a disorder of neuroplasticity. Int Rev Neurobiol 59: 19-45.
52. McCullumsmith RE, Meador-Woodruff JH (2002). Striatal excitatory amino acid transporter transcript expression in schizophrenia, bipolar disorder, and major depressive disorder. Neuropsychopharmacology 26: 368-375.
53. McCullumsmith RE, Kristiansen LV, Beneyto M, Scarr E, Dean B, Meador-Woodruff JH (2007). Decreased NRI, NR2A, and SAP102 transcript expression in the hippocampus in bipolar disorder. Brain Res 1127: 108-118.
54. McDowd JM, Filion DL, Harris MJ, Braff DL (1993). Sensory gating and inhibitory function in late-life schizophrenia. Schizophr Bull 19: 733-746.
55. McIlhinney RA, Le Bourdelles B, Molnar E, Tricaud N, Streit P, Whiting PJ (1998). Assembly intracellular targeting and cell surface expression of the human N-methyl-D-aspartate receptor subunits NR1a and NR2A in transfected cells. Neuropharmacology 37: 1355-1367.
56. McIlhinney RA, Philipps E, Le Bourdelles B, Grimwood S, Wafford K, Sandhu S. et al (2003). Assembly of N-methyl-D-aspartate (NMDA) receptors. Biochem Soc Trans 31: 865-868.
57. Meador-Woodruff JH, Davis KL, Haroutunian V (2001a). Abnormal kainate receptor expression in prefrontal cortex in schizophrenia. Neuropsychopharmacology 24: 545-552.
58. Meador-Woodruff JH, Hogg Jr AJ, Smith RE (2001b). Striatal ionotropic glutamate receptor expression in schizophrenia, bipolar disorder, and major depressive disorder. Brain Res Bull 55: 631-640.
59. Meddows E, Le Bourdelles B, Grimwood S, Wafford K, Sandhu S, Whiting P et al (2001). Identification of molecular determinants that are important in the assembly of N-methyl-D-aspartate receptors. J Biol Chem 276: 18795-18803.
60. Miller JA (1991). The calibration of 35S or 32P with 14C-labeled brain paste or 14C-plastic standards for quantitative autoradiography using LKB Ultrofilm or Amersham Hyperfilm. Neurosci Lett 121: 211-214.
61. Molnar M, Potkin SG, Bunney WE, Jones EG (2003). MRNA expression patterns and distribution of white matter neurons in dorsolateral prefrontal cortex of depressed patients differ from those in schizophrenia patients. Biol Psychiatry 53: 39-47.
62. Moy SS, Perez A, Koller BH, Duncan GE (2006). Amphetamine-induced disruption of prepulse inhibition in mice with reduced NMDA receptor function. Brain Res 1089: 186-194.
63. Mueller HT, Meador-Woodruff JH (2004). NR3A NMDA receptor subunit mRNA expression in schizophrenia, depression and bipolar disorder. Schizophr Res 71: 361-370.
64. Nicolle MM, Baxter MG (2003). Glutamate receptor binding in the frontal cortex and dorsal striatum of aged rats with impaired attentional set-shifting. Eur J Neurosci 18: 3335-3342.
65. Ohnuma T, Kato H, Arai H, Faull R, McKenna P, Emson P (2000). Gene expression of PSD95 in prefrontal cortex and hippocampus in schizophrenia. Neuroreport 11: 3133-3137.
66. Perry EK, Perry RH, Tomlinson BE (1982). The influence of agonal status on some neurochemical activities of postmortem human brain tissue. Neurosci Lett 29: 303-307.
67. Ransom RW, Stec NL (1988). Cooperative modulation of [3H]MK-801 binding to the N-methyl-D-aspartate receptor-ion channel complex by L-glutamate, glycine, and polyamines. J Neurochem 51: 830-836.
68. Roche KW, Standley S, McCallum J, Dune Ly C, Ehlers MD, Wenthold RJ (2001). Molecular determinants of NMDA receptor internalization. Nat Neurosci 4: 794-802.
69. Sans N, Prybylowski K, Petralia RS, Chang K, Wang YX, Racca C et al (2003). NMDA receptor trafficking through an interaction between PDZ proteins and the exocyst complex. Nat Cell Biol 5: 520-530.
70. Sans N, Racca C, Petralia RS, Wang YX, McCallum J, Wenthold RJ (2001). Synapse-associated protein 97 selectively associates with a subset of AMPA receptors early in their biosynthetic pathway. J Neurosci 21: 7506-7516.
71. Schipke CG, Ohlemeyer C, Matyash M, Nolte C, Kettenmann H, Kirchhoff F (2001). Astrocytes of the mouse neocortex express functional N-methyl-D-aspartate receptors. FASEB J 15: 1270-1272.
72. Seifert G, Rehn L, Weber M, Steinhauser C (1997). AMPA receptor subunits expressed by single astrocytes in the juvenile mouse hippocampus. Brain Res Mol Brain Res 47: 286-294.
73. Seifert G, Steinhauser C (1995). Glial cells in the mouse hippocampus express AMPA receptors with an intermediate Ca2+ permeability. Eur J Neurosci 7: 1872-1881.
74. Shao Y, McCarthy KD (1997). Responses of Bergmann glia and granule neurons in situ to N-methyl-D-aspartate, norepinephrine, and high potassium. J Neurochem 68: 2405-2411.
75. Shenolikar S (1995). Protein phosphatase regulation by endogenous inhibitors. Semin Cancer Biol 6: 219-227.
76. Shoemaker JM, Saint Marie RL, Bongiovanni MJ, Neary AC, Tochen LS, Swerdlow NR (2005). Prefrontal D1 and ventral hippocampal N-methyl- D-aspartate regulation of startle gating in rats. Neuroscience 135: 385-394.
77. Siegel BW, Sreekrishna K, Baron BM (1996). Binding of the radiolabeled glycine site antagonist [3H]MDL 105,519 to homomeric NMDA-NR1a receptors. Eur J Pharmacol 312: 357-365.
78. Sills MA, Fagg G, Pozza M, Angst C, Brundish DE, Hurt SD et al (1991). [3H]CGP 39653: a new N-methyl-D-aspartate antagonist radioligand with low nanomolar affinity in rat brain. Eur J Pharmacol 192: 19-24.
79. Sokolov BP (1998). Expression of NMDAR1, GluR1, GluR7, and KA1 glutamate receptor mRNAs is decreased in frontal cortex of 'neuroleptic-free' schizophrenics: evidence on reversible up-regulation by typical neuroleptics. J Neurochem 71: 2454-2464.
80. Staiger JF, Flagmeyer I, Schubert D, Zilles K, Kotter R, Luhmann HJ (2004). Functional diversity of layer IV spiny neurons in rat somatosensory cortex: quantitative morphology of electrophysiologically characterized and biocytin labeled cells. Cereb Cortex 14: 690-701.
81. Standley S, Roche KW, McCallum J, Sans N, Wenthold RJ (2000). PDZ domain suppression of an ER retention signal in NMDA receptor NR1 splice variants. Neuron 28: 887-898.
82. Stratford KJ, Tarczy-Hornoch K, Martin KA, Bannister NJ, Jack JJ (1996). Excitatory synaptic inputs to spiny stellate cells in cat visual cortex. Nature 382: 258-261.
83. Taylor GR, Carter GI, Crow TJ, Johnson JA, Fairbairn AF, Perry EK et al (1986). Recovery and measurement of specific RNA species from postmortem brain tissue: a general reduction in Alzheimer's disease detected by molecular hybridization. Exp Mol Pathol 44: 111-116.
84. Terry-Lorenzo RT, Inoue M, Connor JH, Haystead TA, Armbruster BN, Gupta RP et al (2000). Neurofilament-L is a protein phosphatase-1-binding protein associated with neuronal plasma membrane and post-synaptic density. J Biol Chem 275: 2439-2446.
85. Toro C, Deakin JF (2005). NMDA receptor subunit NRI and postsynaptic protein PSD-95 in hippocampus and orbitofrontal cortex in schizophrenia and mood disorder. Schizophr Res 80: 323-330.
86. Torrey EF, Webster M, Knable M, Johnston N, Yolken RH (2000). The Stanley Foundation brain collection and neuropathology consortium. Schizophr Res 44: 151-155.
87. Toyooka K, Iritani S, Makifuchi T, Shirakawa O, Kitamura N, Maeda K et al (2002). Selective reduction of a PDZ protein, SAP-97, in the prefrontal cortex of patients with chronic schizophrenia. J Neurochem 83: 797-806.
88. Verkhratsky A, Kirchhoff F (2007). NMDA receptors in glia. Neuroscientist 13: 28-37.
89. Verkhratsky A, Steinhauser C (2000). Ion channels in glial cells. Brain Res Brain Res Rev 32: 380-412.
90. Wenthold RJ, Prybylowski K, Standley S, Sans N, Petralia RS (2003a). Trafficking of NMDA receptors. Annu Rev Pharmacol Toxicol 43: 335-358.
91. Wenthold RJ, Sans N, Standley S, Prybylowski K, Petralia RS (2003b). Early events in the trafficking of N-methyl-D-aspartate (NMDA) receptors. Biochem Soc Trans 31: 885-888.
92. White BH, Vogel MW (1996). CGP 39653 binding in the chick CNS after NMDA receptor antagonist treatment. J Neural Transm 103: 1247-1253.
93. Woo TU, Walsh JP, Benes FM (2004). Density of glutamic acid decarboxylase 67 messenger RNA-containing neurons that express the N-methyl-D-aspartate receptor subunit NR2A in the anterior cingulate cortex in schizophrenia and bipolar disorder. Arch Gen Psychiatry 61: 649-657.
94. Yates CM, Butterworth J, Tennant MC, Gordon A (1990). Enzyme activities in relation to pH and lactate in postmortem brain in Alzheimer-type and other dementias. J Neurochem 55: 1624-1630.
95. Ziak D, Chvatal A, Sykova E (1998). Glutamate-, kainate- and NMDA-evoked membrane currents in identified glial cells in rat spinal cord slice. Physiol Res 47: 365-375.